A randomized phase II trial using highly bioavailable curcumin in patients with unresectable advanced pancreatic cancer
Phase 2
- Conditions
- advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000010326
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with active interstitial pneumonia or pulmonary fibrosis 2.Patients with digestive tract obstruction confirmed by imaging test 3.Patients with moderate or severe ascites /pleural effusion 4.Patients with uncontrollable diabetes mellitus, liver dysfunction, severe heart disease 5.Patients with serious infection 6.Patients with a history of severe drug allergy 7.Patients with other serious comorbid diseases 8.Patients with other advanced cancer 9.Pregnant women or patients who wish pregnant 10.Patients with mental diseases 11.Patients who are judged inappropriate for the entry into the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method Quality of life (QOL) score, Time to Treatment Failure, response rate, safety